Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of ($1.22), $0.01 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.71 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• Accenture downgraded by TD Cowen on AI concerns